论文部分内容阅读
目的 :探讨复方中药制剂岩龙口服液对中晚期恶性肿瘤患者化疗时的辅助疗效及毒副反应。方法 :88例各种中晚期恶性肿瘤患者随机分为两组 ,治疗组 47例在化疗基础上辅以岩龙口服液治疗 ,对照组 41例予单纯化疗。结果 :有效率治疗组 5 3 3% ,对照组 2 9 3% ,两组比较 ,差异有显著意义 (P <0 0 5 )。结论 :岩龙口服液有增强抗肿瘤化疗药的疗效、且能降低化疗药对骨髓的抑制作用
Objective : To investigate the adjuvant efficacy and toxic side effects of Compound Longyan Oral Liquid, a traditional Chinese medicine preparation, for patients with advanced malignant tumors. Methods: Eighty-eight patients with advanced and advanced malignant tumors were randomly divided into two groups. 47 patients in the treatment group were treated with Yanlong oral liquid on the basis of chemotherapy, and 41 patients in the control group were treated with chemotherapy alone. Results: The effective treatment group was 533% and the control group was 293%. There was significant difference between the two groups (P < 0.05). Conclusion : Yanlong Oral Liquid can enhance the curative effect of antitumor chemotherapeutics and can reduce the inhibitory effect of chemotherapy drugs on bone marrow